The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.
Source: After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses
Exciting!
Leave a Reply